Alfentanil in low dosage (8 Ilg kg') as an analgesic agent for short duration surgery was evaluated. Forty-one women undergoing laparoscopy received double-blind either alfentanil 8 Ilg kgl or normal saline at induction, and all received thiopentone, alcuronium, enflurane, nitrous oxide and oxygen. The fall in mean arterial pressure (MAP) with induction was similar between groups. The MAP following intubation with alfentanil was unchanged, while with normal saline a mean rise of 23 (SD 15.2) mmHg occurred (P<O.001). The pulse rate following intubation showed a smaller rise (P<O.OOl) with alfentanil of 26 (SD 14.6) beats min-', than the normal saline group of 46 (SD 13.3) beats min-'. Alfentanil was found to be a safe and effective analgesic agent in short duration surgery, by reducing sympathetic responses to intubation without cardiovascular depression or compromise of postoperative recovery.
Alfentanil, a new synthetic derivative of fentanyl, is a potent narcotic analgesic. Alfentanil has approximately one-quarter the potency of fentanyl with a smaller volume of distribution and decreased lipid solubility; 90070 is non-ionised at pH 7.4 and it has a high hepatic clearance. Alfentanil' s pharmacokinetic features allow an early onset of action which may be as little as one circulation time if given as a single bolus, and a predictable duration of action which is less than one-third that of an equipotent dose of fentanyl. [1] [2] [3] [4] [5] [6] Alfentanil has been suggested as an analgesic supplement used at induction of anaesthesia for operations of short duration such as laparoscopy.I,J,7 Other analgesic agents such as fentanyl might take as long as ten minutes to reach peak analgesic effect, or be associated with slow recovery or postoperative respiratory depression. I ,J,7,8 Thiopentone used at induction does not adequately obtund sympathetic responses to intubation. 9 A need exists for an opioid analgesic with a very rapid onset, a short duration of action and the freedom from persistent side effects. 8 This study was designed to assess alfentanil used in low doses (8 Ilg kg-I) as an analgesic supplement to anaesthesia for laparoscopy.
MATERIAL AND METHODS Forty-one female patients of ASA Class I undergoing laparoscopy were studied. The study was approved by the hospital's Medical Ethics Review Committee and all patients gave their informed consent to participate in the study. Upon entry in the trial, patients were randomly assigned into either an alfentanil or saline placebo group.
Coded ampoules containing either alfentanil (500 Ilg mll) or normal saline (0.9%) were prepared and supplied by Janssen Pharmaceutica. On the day of investigation, patients were premedicated with intramusular papaveretum 10 mg and hyoscine 0.2 mg, one hour prior to operation. They received in a double-blind fashion 16 /AI kg· 1 of either saline 0.9070 or alfentanil (i .e. 8 /Ag kg· l ) at the commencement of induction of anaesthesia. Induction was completed with thiopentone (5 mg kg· l ) and a1curonium (0.3 mg kg· l ) with no patient receiving more than 20 mg of a1curonium. Patients were ventilated with nitrous oxide (3 I min· I ), oxygen (1.5 I min· l ) and enfIurane 1 %, and then intubated. Throughout the procedure a lead 11 ECG was ......... ... ... 
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Post recorded continuously and pulse rate (PR) and mean arterial pressure (MAP) were monitored at 60 second intervals using a Dinamap 845.10 EnfIurane was discontinued coincident with the first incision. If systolic arterial pressure rose 20070 above preinduction levels, then additional enflurane was administered as required.
Atropine 1.8 mg and neostigmine 3.75 mg were given towards the end of the operation, to reverse any residual muscle relaxant. Nitrous oxide administration and carbon dioxide absorption were then both terminated. Times of postoperative recovery were measured from time of reversal. Times to spontaneous respiration and to awakening (taken as the time at which the command "Open your eyes" was obeyed) were measured .
Haematology and biochemistry values were measured from blood samples taken immediately prior to induction and while patients were recovering post operatively in the wards.
Evaluation of side-effects such as postoperative nausea and vomiting, and of requirements for postoperative medications (antiemetic, narcotic analgesia and antagonist), was performed by questionnaire interview and by checking of patients' medical records. All patients were interviewed within 24 hours of operation .
RESULTS
The two groups were statistically similar in age, weight, height and operation duration (Table 1) .
Using preinduction MAP and PR as the baselines, the following cardiovascular responses were noted (Figure 1 P<O.OOI) and rose with incision (post incision P<O.OOI). In the alfentanil group, MAP also fell with induction (post induction P<O.OOI) and rose with incision (postincision P<O.OOI). The MAP following intubation in the saline group rose by 23 (SD 15.2) mmHg (P<O.OOI). By contrast MAP in the alfentanil group during this procedure remained unchanged. The normal saline group's PR was raised with induction (postinduction P<O.OOI), intubation (postintubation P<O.OOI) and inCISIOn (postincision P<O.OOI). Similar directional changes occurred in the alfentanil group which exhibited rises with induction (P<O.005), intubation (P<O.OOI) and incision (P<O.OOI). However, with alfentanil these rises with induction and intubation were attenuated. The mean PR rise in the control group following induction and intubation was 26 (SD 16.5) and 46 (SD 13.3) beats mini respectively. By comparison, the alfentanil group displayed significantly attenuated rises in PR of 12 (SD 14.6) (P<O.OOI) and 26 (SD 14.6) beats min'l (P<O.OOI) during these procedures respectively.
Alfentanil did not stabilise postincision MAP or PR rate any better than saline but by this stage the effects of alfentanil may well have diminished. There was no difference in additional enflurane requirements between groups presumably for the same reason ( Table   2 ).
There were no significant differences in recovery times between groups. The time to spontaneous respiration was longer, but time to respond to command was shorter in the alfentanil group (Table 2 ). The incidence of postoperative side effects and the usage of postoperative analgesia and antiemetic was similar ( Table 2) . No narcotic antagonist was required in either group. No patient complained of the induction and none could recall laryngoscopy, intubation or any aspect of the operative procedure.
There was no significant difference in the haematology and biochemistry between normal saline and alfentanil groups. White cell counts rose (P<O.OOI) and sodium concentration fell (P<O.OOI) in both groups postoperatively; all other parameters remained unchanged.
DISCUSSION
This study was designed to evaluate the use of alfentanil in low dosage (8f.1g kg'l) as an Anaesthesia and /lIIcnsiv(' Care. Vol. 14, No. /, February, 1986 analgesic agent used with thiopentone at induction, as part of a technique of balanced anaesthesia in short duration surgery. At this low dosage alfentanil was found to be a safe and effective analgesic agent with no more side effects than saline. By comparison with the use of thiopentone alone in the saline group, the use of low-dose alfentanil substantially diminished sympathetic responses (tachycardia and hypertension) without cardiovascular depression or compromise of postoperative recovery.
Alfentanil has been used in doses up to 225 f.lg kg'I, depending on age, physical status and premedication. 4,8, II Induction with alfentanil alone at these high doses successfully blocked increases in heart rate and arterial pressure seen during tracheal intubation. Alfentanil, like fentanyl, has minimal myocardial depressant effect. 9 Thus alfentanil may be suitable for patients with cardiac disease. One study estimated the ED90 of alfentanil as the sole induction agent as 169 f.lg kg'l, in un premedicated young adults. II At these high doses, a high incidence of upper limb movements and chest wall rigidity, which necessitated muscle relaxants, was noted. Low-dose alfentanil given at induction did not obtund sympathetic responses to operative incision any better than saline. Alfentanil in single intravenous bolus doses is a very shortacting agent, because of its redistribution and short elimination phase. II , 12 Alfentanil may be better used in divided doses, such that a small initial bolus (8 JAg kg· l ) could be followed by small increments (4 JAg kg· l ) immediately before and during surgery. 7, 8 Low-dose alfentanil had as rapid a postoperative recovery as the saline group. Alfentanil has been shown in some studies to be of significant advantage over fentanyl as an analgesic supplement for short procedures when recovery of perception, reaction and manipulation is important as in day-case surgery. 13, 14, 15 Thus, alfentanil may be used with advantage replacing fentanyl in short duration surgery. 16 
